ANEB News and Press, Anebulo Pharmaceuticals Inc.

CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced it has reached a cooperation agreemen...

A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.2% to $126.57 on volume of 604,432,871 shares American Rebel Holdings Inc. (AREB) rose 152.5% to $0.76 on volume of 367,740,589 shares Sirius XM Holdings Inc. (SIRI) rose 1.0% to $2.93 on volume of 329...

2024-05-16 11:10:45 ET More on Anebulo Pharmaceuticals Seeking Alpha’s Quant Rating on Anebulo Pharmaceuticals Historical earnings data for Anebulo Pharmaceuticals Read the full article on Seeking Alpha For further details see: Anebulo Pharmaceutic...

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid toxicities that include acute cannabinoid intoxication (ACI) and unintentional cannabis poisoning (the “Company” or ...

A look at the top 10 most actives in the United States AMC Entertainment Holdings Inc. Class A (AMC) rose 78.4% to $5.19 on volume of 478,215,489 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 32.3% to $0.061 on volume of 267,439,891 shares GameStop Corporation (GME) rose 74....

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse (the “Company” or “Anebulo”), today announced financial results for ...

Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...

2023-11-15 08:49:55 ET More on Anebulo Pharmaceuticals Seeking Alpha’s Quant Rating on Anebulo Pharmaceuticals Historical earnings data for Anebulo Pharmaceuticals Financial information for Anebulo Pharmaceuticals For further details see: Anebulo P...

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse (the “Company” or “Anebulo”), today announced financial results for ...